Skip to main content
Ovarian Cancer, PARP Inhibitors
PARP Inhibitors in Ovarian Cancer: Choice May Depend on Treatment Setting, Mutation Status, and Side-Effect Profile
Read More
Ovarian Cancer
Time to First Subsequent Therapy Longer in Patients with Advanced Ovarian Cancer Who Are Treated with Niraparib
Read More
Original Research, Oral Therapy, Thromboembolism
Venous Thromboembolism Management in Ambulatory Patients with Cancer: Dawn of the Oral Anticoagulant Era?
Sarah L. Hanson, PharmD, Christina Maher, PharmD, Jai N. Patel, PharmD, BCOP
Sarah L. Hanson, PharmD; Christina Maher, PharmD; Jai N. Patel, PharmD, BCOP
Read More
Original Research, Dose Escalation/Reduction, Multiple Myeloma, Transplant
Impact of Weight-Based Melphalan Dosing Strategies in Autologous Hematopoietic Stem-Cell Transplant for Multiple Myeloma
Erin K. Yeung, PharmD, BCPS, John Malamakal, PharmD, MS, BCPS, BCOP
Erin K. Yeung, PharmD, BCPS; John Malamakal, PharmD, MS, BCPS, BCOP
Read More
Original Research, Transplant
Risk Factors for Subtherapeutic Tacrolimus Levels After Conversion from Intravenous to Oral Dosing Posttransplant in Adults
Kelsey Konrardy, PharmD, Kane M. Hosmer, PharmD, BCOP, Michelle Rockey, PharmD, BCOP, FHOPA, Zahra Mahmoudjafari, PharmD, BCOP, Dennis W. Grauer, MS, PhD, David W. Henry, MS, RPh, BCOP, FASHP, Leyla Shune, MD, Joseph McGuirk, DO
Kelsey Konrardy, PharmD; Kane Hosmer, PharmD, BCOP; Michelle Rockey, PharmD, BCOP, FHOPA; Zahra Mahmoudjafari, PharmD, BCOP; Dennis Grauer, MS, PhD; David Henry, MS, BCOP, FASHP; Leyla Shune, MD; Joseph McGuirk, DO
Read More
Case Reports, Leukemia, Methotrexate
Monitoring Methotrexate Levels in a Patient After Glucarpidase Administration: A Case Report
Savannah L. Gulley, PharmD, Kyle A. Franco, PharmD, BCPPS, Joshua J. Elder, PharmD, BCPS, BCOP
Savannah L. Gulley, PharmD; Kyle A. Franco, PharmD, BCPPS; Joshua J. Elder, PharmD, BCPS, BCOP
Read More
HOPA Highlights
What’s New in the Oncology Drug Pipeline?
Meg Barbor, MPH
Meg Barbor, MPH
Read More
HOPA Highlights, Immunotherapy, Lung Cancer, Screening
The Intersection of Immunotherapy and Targeted Therapy in Lung Cancer
Meg Barbor, MPH
Meg Barbor, MPH
Read More
HOPA Highlights, Disparities in Oncology Care
The Cancer Care Gap in Rural America: A 50-Million People Conundrum
Meg Barbor, MPH
Meg Barbor, MPH
Read More
Symptom Management Overview, Oral Therapy
Direct Oral Anticoagulant Therapy for Heparin-Induced Thrombocytopenia—A New Alternative?
Zain Al-Jammali, PharmD, Harleen Singh, PharmD, BCACP, Joseph Bubalo, PharmD, BCPS, BCOP, Joseph Shatzel, MD
Zain Al-Jammali, PharmD; Harleen Singh, PharmD, BCACP; Joseph Bubalo, PharmD, BCOP; Joseph Shatzel, MD
Read More
Page 133 of 198
Results 1321 - 1330 of 1974